☰

Glendon M. Zinser, Ph.D. - Publications

Affiliations: 
2003 University of Notre Dame, Notre Dame, IN, United States 
 2005-2012 University of Cincinnati, Cincinnati, OH 
Area:
Cell Biology, Molecular Biology, Oncology
Website:
https://researchdirectory.uc.edu/p/zinserg
Tree Info Grants Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Johnson AL, Zinser GM, Waltz SE. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity. Oncotarget. 6: 16304-20. PMID 26008979 DOI: 10.18632/Oncotarget.4059  0.805
2015 Benight NM, Wagh PK, Zinser GM, Peace BE, Stuart WD, Vasiliauskas J, Pathrose P, Starnes SL, Waltz SE. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses. Oncotarget. 6: 17445-61. PMID 25938541 DOI: 10.18632/Oncotarget.3641  0.717
2014 Johnson AL, Zinser GM, Waltz SE. Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. American Journal of Physiology. Endocrinology and Metabolism. 307: E674-85. PMID 25139050 DOI: 10.1152/Ajpendo.00200.2014  0.756
2012 Wagh PK, Zinser GM, Gray JK, Shrestha A, Waltz SE. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis. Endocrinology. 153: 2735-46. PMID 22474186 DOI: 10.1210/En.2011-1543  0.846
2011 Ching S, Kashinkunti S, Niehaus MD, Zinser GM. Mammary adipocytes bioactivate 25-hydroxyvitamin D₃ and signal via vitamin D₃ receptor, modulating mammary epithelial cell growth. Journal of Cellular Biochemistry. 112: 3393-405. PMID 21769914 DOI: 10.1002/jcb.23273  0.527
2011 Wagh PK, Gray JK, Zinser GM, Vasiliauskas J, James L, Monga SP, Waltz SE. β-Catenin is required for Ron receptor-induced mammary tumorigenesis. Oncogene. 30: 3694-704. PMID 21423209 DOI: 10.1038/Onc.2011.86  0.839
2011 Welsh J, Zinser LN, Mianecki-Morton L, Martin J, Waltz SE, James H, Zinser GM. Age-related changes in the epithelial and stromal compartments of the mammary gland in normocalcemic mice lacking the vitamin D3 receptor. Plos One. 6: e16479. PMID 21298063 DOI: 10.1371/Journal.Pone.0016479  0.768
2010 Meyer SE, Peace BE, Bahassi el M, Kavanaugh GM, Wagh PK, Robbins SB, Yin M, Wells SI, Zinser GM, Stambrook PJ, Waltz SE. Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice. Cancer Letters. 296: 186-93. PMID 20434834 DOI: 10.1016/J.Canlet.2010.04.011  0.787
2010 Matthews D, LaPorta E, Zinser GM, Narvaez CJ, Welsh J. Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells. The Journal of Steroid Biochemistry and Molecular Biology. 121: 362-7. PMID 20412854 DOI: 10.1016/j.jsbmb.2010.03.061  0.732
2009 Korecki CL, Zinser G, Liu X, Siedler J, Welsh J, Niebur GL. Effect of the vitamin D receptor on bone geometry and strength during gestation and lactation in mice. Calcified Tissue International. 85: 405-11. PMID 19763375 DOI: 10.1007/S00223-009-9281-3  0.617
2009 Meyer SE, Zinser GM, Stuart WD, Pathrose P, Waltz SE. The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis. Developmental Biology. 333: 173-85. PMID 19576199 DOI: 10.1016/J.Ydbio.2009.06.028  0.781
2007 Mordan-McCombs S, Valrance M, Zinser G, Tenniswood M, Welsh J. Calcium, vitamin D and the vitamin D receptor: impact on prostate and breast cancer in preclinical models. Nutrition Reviews. 65: S131-3. PMID 17867390 DOI: 10.1111/J.1753-4887.2007.Tb00341.X  0.809
2007 Mordan-McCombs S, Brown T, Zinser G, Welsh J, Tenniswood M. Dietary calcium does not affect prostate tumor progression in LPB-Tag transgenic mice. The Journal of Steroid Biochemistry and Molecular Biology. 103: 747-51. PMID 17307354 DOI: 10.1016/J.Jsbmb.2006.12.073  0.66
2006 Zinser GM, Leonis MA, Toney K, Pathrose P, Thobe M, Kader SA, Peace BE, Beauman SR, Collins MH, Waltz SE. Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation. Cancer Research. 66: 11967-74. PMID 17178895 DOI: 10.1158/0008-5472.Can-06-2473  0.779
2006 Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance M, Aranda A, Moras D, Norman A, Welsh J, Byers SW. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Molecular Cell. 21: 799-809. PMID 16543149 DOI: 10.1016/J.Molcel.2006.01.037  0.77
2006 Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance M, Aranda A, Moras D, Norman A, Welsh J, Byers SW. The Molecular Basis of Vitamin D Receptor and β-Catenin Crossregulation (DOI:10.1016/j.molcel.2006.01.037) Molecular Cell. 22: 148. DOI: 10.1016/J.Molcel.2006.03.020  0.796
2005 Zinser GM, Suckow M, Welsh J. Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues. The Journal of Steroid Biochemistry and Molecular Biology. 97: 153-64. PMID 16111884 DOI: 10.1016/J.Jsbmb.2005.06.024  0.754
2005 Zinser GM, Tribble E, Valrance M, Urben CM, Knutson JC, Mazess RB, Strugnell SA, Welsh J. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors. Anticancer Research. 25: 235-41. PMID 15816543  0.825
2004 Zinser GM, Welsh J. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis. 25: 2361-72. PMID 15333467 DOI: 10.1093/Carcin/Bgh271  0.768
2004 Zinser GM, Welsh J. Effect of Vitamin D3 receptor ablation on murine mammary gland development and tumorigenesis. The Journal of Steroid Biochemistry and Molecular Biology. 89: 433-6. PMID 15225815 DOI: 10.1016/J.Jsbmb.2004.03.012  0.723
2004 Zinser GM, Welsh J. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. Molecular Endocrinology (Baltimore, Md.). 18: 2208-23. PMID 15178742 DOI: 10.1210/Me.2003-0469  0.745
2003 Welsh J, Wietzke JA, Zinser GM, Byrne B, Smith K, Narvaez CJ. Vitamin D-3 receptor as a target for breast cancer prevention. The Journal of Nutrition. 133: 2425S-2433S. PMID 12840219 DOI: 10.1093/Jn/133.7.2425S  0.809
2003 Zinser GM, McEleney K, Welsh J. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Molecular and Cellular Endocrinology. 200: 67-80. PMID 12644300 DOI: 10.1016/S0303-7207(02)00416-1  0.756
2002 Welsh J, Wietzke JA, Zinser GM, Smyczek S, Romu S, Tribble E, Welsh JC, Byrne B, Narvaez CJ. Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 83: 85-92. PMID 12650704 DOI: 10.1016/S0960-0760(02)00277-7  0.815
2002 Zinser GM, Sundberg JP, Welsh J. Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis. 23: 2103-9. PMID 12507934 DOI: 10.1093/Carcin/23.12.2103  0.721
2002 Zinser G, Packman K, Welsh J. Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development (Cambridge, England). 129: 3067-76. PMID 12070083  0.826
2001 Narvaez CJ, Zinser G, Welsh J. Functions of 1alpha,25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer. Steroids. 66: 301-8. PMID 11179738 DOI: 10.1016/S0039-128X(00)00202-6  0.748
Show low-probability matches.